Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
FDA Grants Orphan Drug Status to UniQure's AMT-191, Aiming to Treat Fabry Disease
UniQure Biopharma Granted Orphan Drug Designation For Its 'Adeno-associated Viral Vector Serotype 5 Encoding Human Alpha-galactosidase A' For The Treatment Of Fabry Disease
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright analyst Patrick Trucchio maintains $uniQure NV(QURE.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 29.0%
HC Wainwright & Co. Reiterates Buy on UniQure, Maintains $25 Price Target
UniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease
UniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
UniQure to Cut 65% of Workforce, or 300 Jobs, in Major Restructuring
Goldman Sachs Maintains Neutral on UniQure, Raises Price Target to $10
UniQure Analyst Ratings
RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $16
RBC Capital analyst Luca Issi maintains $uniQure NV(QURE.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate of 29.0% and a total
UniQure GAAP EPS of -$1.16, Revenue of $11.1M
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $14 to $16
On Aug 02, major Wall Street analysts update their ratings for $uniQure NV(QURE.US)$, with price targets ranging from $14 to $16.Wells Fargo analyst Yanan Zhu maintains with a hold rating, and
Express News | Uniqure NV : Mizuho Raises Target Price to $7 From $6
UniQure Q2 2024 GAAP EPS $(1.16), Inline, Sales $11.126M Beat $6.260M Estimate
uniQure NV | 10-Q: Q2 2024 Earnings Report
Earnings Flash (QURE) UNIQURE Posts Q2 Revenue $11.1M
UniQure: Runway To Fund Operations Through End 2027 >QURE
UniQure Sets Organizational Restructuring Aimed at Streamlining Operations >QURE
UniQure 2Q Loss/Shr $1.16 >QURE